EVP, Chief Revenue Officer

EVP & President Connected Care

EVP & Pres Med.Essntl&BioPharm

Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.

Institution	Shares	Value	Change
Greenhaven Associates	5,681,708	$860M	NEW
Fort Washington Investment Advisors Inc /OH	1,107,849	$168M	INCREASED
Davenport &	628,589	$96M	DECREASED
River Road Asset Management	413,651	$63M	DECREASED
Exchange Traded Concepts	328,565	$50M	INCREASED

Insider	Type	Shares	Value	Date
Michael Feld (EVP, Chief Revenue Officer)	SELL	75	$12K	2026-07-27
Bilal Muhsin (EVP & President Connected Care)	SELL	1,935		2026-07-01
Bilal Muhsin (EVP & President Connected Care)	AWARD	14,342		2026-07-01
Michael Feld (EVP, Chief Revenue Officer)	SELL	75	$11K	2026-06-26
Michael David Garrison (EVP & Pres Med.Essntl&BioPharm)	SELL	1,100	$160K	2026-06-24

Becton, Dickinson and Co. (BDX) Ownership & Trading Activity

Top Institutional Holders

Recent Insider Trades

Recent Congressional Trades